Page last updated: 2024-09-03

cholestane-3,5,6-triol and Acute Brain Injuries

cholestane-3,5,6-triol has been researched along with Acute Brain Injuries in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Chen, W; Hu, H; Huang, Y; Leng, T; Liu, A; Qiu, P; Sang, H; Tang, L; Wang, L; Wang, Y; Yan, G; Yin, W; You, X; Zhang, J; Zhou, Y1

Other Studies

1 other study(ies) available for cholestane-3,5,6-triol and Acute Brain Injuries

ArticleYear
The major cholesterol metabolite cholestane-3β,5α,6β-triol functions as an endogenous neuroprotectant.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014, Aug-20, Volume: 34, Issue:34

    Topics: Adult; Animals; Brain Injuries; Cells, Cultured; Central Nervous System; Cholestanols; Disease Models, Animal; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Humans; Infarction, Middle Cerebral Artery; Male; Neurons; Neuroprotective Agents; Protein Binding; Rabbits; Rats; Rats, Sprague-Dawley; Spinal Cord Ischemia; Time Factors; Tissue Distribution; Young Adult

2014